Jardiance (empagliflozin) - Eli Lilly, Boehringer Ingelheim
EMPA[10-20]: Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2 (clinicaltrials.gov) - Sep 11, 2026 - P4 | N=34 | Recruiting | Sponsor: Centre Hospitalier Universitaire de Nice | Not yet recruiting ➔ Recruiting 
Enrollment open • Chronic Kidney Disease • Nephrology • Renal Disease
http://clinicaltrials.gov/ct2/show/NCT07074418
 
Sep 11, 2026
 
Prev Next